Dermatol. praxi. 2010;4(3):131-135

Scalp psoriasis and current therapeutic options

MUDr.Martin Tichý, Ph.D., doc.MUDr.Dagmar Ditrichová, CSc.
Klinika chorob kožních a pohlavních LF UP a FNOL

Psoriasis is among the most common skin conditions affecting the scalp. It is a chronic inflammatory disease that significantly reduces the

quality of life of the patients; therefore, emphasis is placed on optimizing the therapeutic procedures. The present article provides an

overview of current therapeutic options.

Keywords: psoriasis, scalp, therapeutic options

Published: November 20, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tichý M, Ditrichová D. Scalp psoriasis and current therapeutic options. Dermatol. praxi. 2010;4(3):131-135.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha: Triton, 2007: 190 s.
    2. van de Kerkhof PC, Franssen ME. Psoriasis of the scalp. Diagnosis and manage. Am J Clin Dermatol 2001; 2: 159-165. Go to original source... Go to PubMed...
    3. Štolfa J, Pavelka K, Vencovský J. Standardní postupy v léčbě psoriatické artritidy. Čes. Revm 2005; 3: 97-110.
    4. Papp K, Berth-Jones J, Kragballe K, Wozel G, de la Brassinne M. Scalp psoriasis: a review of current topical treatment options. JEADV 2007; 21: 1151-1160. Go to original source... Go to PubMed...
    5. Mason J, Mason AR, Cork MJ. Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 2002; 146: 351-364. Go to original source... Go to PubMed...
    6. Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasole propionate 0,05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. J Dermatolog Treat 2006; 17: 90-95. Go to original source... Go to PubMed...
    7. Feldman SR, Housman TS. Patients´vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol 2003; 4: 221-224. Go to original source... Go to PubMed...
    8. Stein L. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. J Am Acad Dermatol 2005; 53(Suppl. 1): S39-S49. Go to original source... Go to PubMed...
    9. van der Vleuten CJ, van de Kerkhof PC. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment. Drugs 2001; 61: 1593-1598. Go to original source... Go to PubMed...
    10. Ramsay CA, Berth-Jones J, Brundin G, et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-264. Go to original source... Go to PubMed...
    11. Duweb G, Alhaddar J, Abuhamida M. Calcipotriol solution in scalp psoriasis. Int J Tissue React 2005; 27: 163-166. Go to PubMed...
    12. Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. Br J Dermatol 2006; 154: 1155-1160. Go to original source... Go to PubMed...
    13. Downs AMR. Overnight application of Daivobet ointment is effective in scalp psoriasis. Br J Dermatol 2004; 151(Suppl. 68): 52-53.
    14. Buckley C, Shapiro J, Saari S, et al. Calcipotriol plus betamethasone dipropionate (LEO80185) gel is effective and safe in the treatment of scalp psoriasis (a phase II study). J Eur Acad Dermatol Venereol 2005; 19(Suppl. 2): 175.
    15. Langner A, Wolska H, Hebborn P. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutis 1983; 32: 295-296.
    16. Haas N, Wulff-Woesten A, Sterry W, Meffert H. Dithranol in the treatment of scalp psoriasis. J Dtsch Dermatol Ges 2003; 1: 688-693. Go to original source... Go to PubMed...
    17. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dertmatol 2004; 51: 785-798. Go to original source... Go to PubMed...
    18. Jury CS, Hugh McL, Shankland GS, et al. A randomized, placebo-controlled trial of oral itraconazole in scalp psoriasis. J Dermatol Treat 2000; 11: 85-89. Go to original source...
    19. Rosenberg EW, Belew PW. Improvement of psoriasis of the scalp with ketoconazole. Arch Dermatol 1982; 118: 370-371. Go to original source... Go to PubMed...
    20. Tajena A, Racette A, Gourgouliatos Z, Tailor CR. Broad-band UVB fiber - optic comb for the treatment of scalp psoriasis: a pilot study. Int J Dermatol 2004; 43: 462-467. Go to original source... Go to PubMed...
    21. Lindelof B. Grenz ray therapy in dermatology. An experimental, clinical and epidemiological study. Acta Derm Venereol Suppl (Stockh) 1987; 132: 1-67. Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.